Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 3/2014

Open Access 01-06-2014 | Research

Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation

Authors: Julien Poissy, Boualem Sendid, Sébastien Damiens, Ken Ichi Ishibashi, Nadine François, Marie Kauv, Raphaël Favory, Daniel Mathieu, Daniel Poulain

Published in: Critical Care | Issue 3/2014

Login to get access

Abstract

Introduction

Prompt diagnosis of candidaemia and invasive candidosis is crucial to the early initiation of antifungal therapy. The poor sensitivity of blood cultures (BCs) has led to the development of fungal glycan tests as a diagnostic adjunct. We analysed the performance of tests for the detection of circulating β-D-1,3-glucan (BDG) and mannan in the intensive care unit (ICU) setting.

Methods

This retrospective, case–control study included 43 ICU patients with candidaemia and 67 controls, hospitalised on the same ward and assessed weekly for yeast colonisation with simultaneous serum sampling; 340 sera taken before and after positive BCs were available for the cases group and 203 for the controls. BDG and mannan levels were determined using the Fungitell® and Platelia™ Candida Ag tests, respectively.

Results

BDG was detected early in sera from cases patients but was also present in several sera from controls. Increasing the cut-off from 80 pg/mL to 350 pg/mL and 800 pg/mL resulted in sensitivity/specificity ratios of 0.97/0.31, 0.65/0.74, 0.30/0.86, respectively. Detection of mannan was more specific but lacked sensitivity. No obvious correlation was found between BDG and colonisation, but a trend existed between high colonisation and high BDG. Candidaemia relapses were associated with a rise in BDG and mannan but, in contrast to the transient nature of mannan, BDG persisted up to 7 weeks after positive BCs.

Conclusion

A combination of mannan and BDG tests could be used to guide pre-emptive therapeutic decisions in ICU patients.
Appendix
Available only for authorised users
Literature
1.
Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348: 1546-1554. 10.1056/NEJMoa022139PubMedCrossRef
2.
Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D: Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003, 37: 1172-1177. 10.1086/378745PubMedCrossRef
3.
Kett DH, Azoulay E, Echeverria PM, Vincent JL: Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 2011, 39: 665-670. 10.1097/CCM.0b013e318206c1caPubMedCrossRef
4.
Morrell M, Fraser VJ, Kollef MH: Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005, 49: 3640-3645. 10.1128/AAC.49.9.3640-3645.2005PubMedPubMedCentralCrossRef
5.
Kollef M, Micek S, Hampton N, Doherty JA, Kumar A: Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 2012, 54: 1739-1746. 10.1093/cid/cis305PubMedCrossRef
6.
Clancy CJ, Nguyen MH: Finding the ‘missing 50%’ of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 2013, 56: 1284-1292. 10.1093/cid/cit006PubMedCrossRef
7.
Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K: Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996, 33: 23-32. 10.1016/S0163-4453(96)92700-0PubMedCrossRef
8.
Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ: Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diag Microbiol Infect Dis 1993, 17: 103-109. 10.1016/0732-8893(93)90020-8CrossRef
9.
Meyer MH, Letscher-Bru V, Jaulhac B, Waller J, Candolfi E: Comparison of Mycosis IC/F and plus Aerobic/F media for diagnosis of fungemia by the bactec 9240 system. J Clin Microbiol 2004, 42: 773-777. 10.1128/JCM.42.2.773-777.2004PubMedPubMedCentralCrossRef
10.
Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD, Infectious Diseases Society of America: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 48: 503-535. 10.1086/596757PubMedCrossRef
11.
Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP, Jensen HE, Lass-Florl C, Richardson MD, Akova M, Bassetti M, Calandra T, Castagnola E, Cornely OA, Garbino J, Groll AH, Herbrecht R, Hope WW, Kullberg BJ, Lortholary O, Meersseman W, Petrikkos G, Roilides E, Viscoli C, Ullmann AJ: ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012, 18: 9-18.PubMedCrossRef
12.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41: 580-637. 10.1097/CCM.0b013e31827e83afPubMedCrossRef
13.
Mohr JF, Sims C, Paetznick V, Rodriguez J, Finkelman MA, Rex JH, Ostrosky-Zeichner L: Prospective survey of (1 → 3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J Clin Microbiol 2011, 49: 58-61. 10.1128/JCM.01240-10PubMedPubMedCentralCrossRef
14.
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, et al.: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46: 1813-1821. 10.1086/588660PubMedPubMedCentralCrossRef
15.
Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A, Yamaguchi H, Shimada K, Kawai T: Plasma (1 → 3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995, 345: 17-20. 10.1016/S0140-6736(95)91152-9PubMedCrossRef
16.
Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME: β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011, 52: 750-770. 10.1093/cid/ciq206PubMedCrossRef
17.
Ueda Y, Ohwada S, Abe Y, Shibata T, Iijima M, Yoshimitsu Y, Koshiba T, Nakata M, Ueda T, Kawabata S: Factor G utilizes a carbohydrate-binding cleft that is conserved between horseshoe crab and bacteria for the recognition of beta-1,3-D-glucans. J Immunol 2009, 183: 3810-3818.PubMedCrossRef
18.
Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH: Multicenter clinical evaluation of the (1 → 3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005, 41: 654-659. 10.1086/432470PubMedCrossRef
19.
Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Press EG, Shields RM, Cheng S, Mitsani D, Vadnerkar A, Silveira FP, Kleiboeker SB, Clancy CJ: Performance of Candida real-time polymerase chain reaction, beta-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012, 54: 1240-1248. 10.1093/cid/cis200PubMedCrossRef
20.
Posteraro B, De Pascale G, Tumbarello M, Torelli R, Pennisi MA, Bello G, Maviglia R, Fadda G, Sanguinetti M, Antonelli M: Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1 → 3)-beta-D-glucan assay, Candida score, and colonization index. Crit Care 2011, 15: R249. 10.1186/cc10507PubMedPubMedCentralCrossRef
21.
Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A: Contribution of the (1 → 3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbol 2008, 46: 1009-1013. 10.1128/JCM.02091-07CrossRef
22.
Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D: Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diag Lab Immunol 2003, 10: 882-885.
23.
Theel ES, Doern CD: Point–Counterpoint: β-D-glucan is an important test in the diagnosis of invasive fungal infections. J Clin Microbiol 2013, 51: 3478-3483. 10.1128/JCM.01737-13PubMedPubMedCentralCrossRef
24.
Senn L, Robinson JO, Schmidt S, Knaup M, Asahi N, Satomura S, Matsuura S, Duvoisin B, Bille J, Calandra T, Marchetti O: 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008, 46: 878-885. 10.1086/527382PubMedCrossRef
25.
Jaijakul S, Vazquez JA, Swanson RN, Ostrosky-Zeichner L: (1,3)-Beta-D-glucan as a prognostic marker of treatment response in invasive candidiasis. Clin Infect Dis 2012, 55: 521-526. 10.1093/cid/cis456PubMedCrossRef
26.
Ishibashi K, Yoshida M, Nakabayashi I, Shinohara H, Miura NN, Adachi Y, Ohno N: Role of anti-beta-glucan antibody in host defense against fungi. FEMS Immunol Med Microbiol 2005, 44: 99-109. 10.1016/j.femsim.2004.12.012PubMedCrossRef
27.
Chiani P, Bromuro C, Cassone A, Torosantucci A: Anti-beta-glucan antibodies in healthy human subjects. Vaccine 2009, 27: 513-519. 10.1016/j.vaccine.2008.11.030PubMedCrossRef
28.
Sendid B, Dotan N, Nseir S, Savaux C, Vandewalle P, Standaert A, Zerimech F, Guery BP, Dukler A, Colombel JF, Poulain D: Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan. Clin Vaccine Immunol 2008, 15: 1868-1877. 10.1128/CVI.00200-08PubMedPubMedCentralCrossRef
29.
Yauch L, Lam J, Levitz S: Direct inhibition of T-cell responses by the Cryptococcus capsula polysaccharide glucuronoxylomannan. PLoS Pathog 2006, 2: e120. 10.1371/journal.ppat.0020120PubMedPubMedCentralCrossRef
30.
31.
Held J, Kohlberger I, Rappold E, Busse Grawitz A, Hacker G: Comparison of (1 → 3)-beta-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia. J Clin Microbiol 2013, 51: 1158-1164. 10.1128/JCM.02473-12PubMedPubMedCentralCrossRef
32.
Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F: Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother 2011, 55: 532-538. 10.1128/AAC.01128-10PubMedPubMedCentralCrossRef
33.
Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, Poulain D: New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol 1999, 37: 1510-1517.PubMedPubMedCentral
34.
Damiens S, Poissy J, Francois N, Salleron J, Jawhara S, Jouault T, Poulain D, Sendid B: Mannose-binding lectin levels and variation during invasive candidiasis. J Clin Immunol 2012, 32: 1317-1323. 10.1007/s10875-012-9748-2PubMedCrossRef
35.
Sendid B, Poirot JL, Tabouret M, Bonnin A, Caillot D, Camus D, Poulain D: Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol 2002, 51: 433-442.PubMedCrossRef
36.
Morace G, Borghi E: Fungal infections in ICU patients: epidemiology and the role of diagnostics. Minerva Anestesiol 2010, 76: 950-956.PubMed
37.
38.
Charles PE, Dalle F, Aube H, Doise JM, Quenot JP, Aho LS, Chavanet P, Blettery B: Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med 2005, 31: 393-400. 10.1007/s00134-005-2571-yPubMedCrossRef
39.
Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M, Marchetti O: β-glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference On Infection in Leukemia (ECIL3). Clin Infect Dis 2012, 54: 633-643. 10.1093/cid/cir897PubMedCrossRef
40.
Schuster MG, Edwards JE Jr, Sobel JD, Darouiche RO, Karchmer AW, Hadley S, Slotman G, Panzer H, Biswas P, Rex JH: Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 2008, 149: 83-90. 10.7326/0003-4819-149-2-200807150-00004PubMedCrossRef
41.
Golan Y, Wolf MP, Pauker SG, Wong JB, Hadley S: Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. Ann Intern Med 2005, 143: 857-869. 10.7326/0003-4819-143-12-200512200-00004PubMedCrossRef
42.
Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH: Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis Clin Microbiol 2007, 26: 271-276. 10.1007/s10096-007-0270-zCrossRef
43.
Leon C, Ruiz-Santana S, Saavedra P, Galvan B, Blanco A, Castro C, Balasini C, Utande-Vazquez A, De Gonzalez De Molina FJ, Blasco-Navalproto MA, López MJ, Charles PE, Martín E, Hernández-Viera MA, Cava Study Group: Usefulness of the ‘Candida score’ for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009, 37: 1624-1633. 10.1097/CCM.0b013e31819daa14PubMedCrossRef
Metadata
Title
Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation
Authors
Julien Poissy
Boualem Sendid
Sébastien Damiens
Ken Ichi Ishibashi
Nadine François
Marie Kauv
Raphaël Favory
Daniel Mathieu
Daniel Poulain
Publication date
01-06-2014
Publisher
BioMed Central
Published in
Critical Care / Issue 3/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc13953

Other articles of this Issue 3/2014

Critical Care 3/2014 Go to the issue

Commentary

Renal recovery after acute kidney injury: choice of initial renal replacement therapy modality still matters

Research

Inflammation biomarkers and delirium in critically ill patients

Journal club critique

‘To prone or not to prone’ in severe ARDS: questions answered, but others remain

Journal club critique

High-frequency oscillation in early adult respiratory distress syndrome

Research

Detection of ‘best’ positive end-expiratory pressure derived from electrical impedance tomography parameters during a decremental positive end-expiratory pressure trial

Research

Clinical assessment of peripheral perfusion to predict postoperative complications after major abdominal surgery early: a prospective observational study in adults